Azithromycin: Effective Single-Dose Antibiotic Treatment
| Product dosage: 0.25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.54 | $48.30 (0%) | 🛒 Add to cart |
| 120 | $0.49 | $64.40 $59.37 (8%) | 🛒 Add to cart |
| 180 | $0.46 | $96.60 $83.52 (14%) | 🛒 Add to cart |
| 270 | $0.44 | $144.90 $117.74 (19%) | 🛒 Add to cart |
| 360 | $0.42
Best per pill | $193.21 $152.96 (21%) | 🛒 Add to cart |
Synonyms | |||
Azithromycin is a macrolide antibiotic indicated for the treatment of a wide range of bacterial infections. Known for its convenient once-daily dosing and broad-spectrum activity, it targets common pathogens responsible for respiratory, skin, and sexually transmitted infections. Its extended tissue half-life allows for shorter treatment courses compared to many alternatives, supporting patient adherence and clinical efficacy.
Features
- Active ingredient: Azithromycin dihydrate
- Available in 250 mg and 500 mg oral tablets
- Also available as powder for oral suspension (100 mg/5 mL and 200 mg/5 mL)
- Extended spectrum of activity covering Gram-positive, Gram-negative, and atypical bacteria
- FDA-approved for multiple indications including community-acquired pneumonia, streptococcal pharyngitis, and uncomplicated skin infections
- Stable at room temperature with standard shelf life of 24 months
Benefits
- Convenient once-daily dosing regimen improves patient compliance
- Short-course therapy (typically 3–5 days) due to prolonged antibacterial activity
- Effective against common respiratory pathogens including Streptococcus pneumoniae and Haemophilus influenzae
- Well-established safety profile with extensive clinical use worldwide
- Suitable for pediatric populations in suspension form
- May be taken with or without food, offering dosing flexibility
Common use
Azithromycin is commonly prescribed for bacterial infections including acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia, streptococcal pharyngitis, uncomplicated skin and skin structure infections, nongonococcal urethritis and cervicitis, and genital ulcer disease. Off-label uses may include prevention and treatment of Mycobacterium avium complex in immunocompromised patients and treatment of certain gastrointestinal infections.
Dosage and direction
Adults: For most indications, 500 mg as a single dose on day 1, followed by 250 mg once daily on days 2 through 5. For sexually transmitted diseases: single 1 gram dose. Children: Dosage based on body weight for oral suspension. Typically 10 mg/kg on day 1 (maximum 500 mg), then 5 mg/kg on days 2–5 (maximum 250 mg). Take at least 1 hour before or 2 hours after meals, though may be taken with food if gastrointestinal upset occurs. Complete the full prescribed course even if symptoms improve.
Precautions
Use with caution in patients with hepatic impairment. Monitor for signs of hepatotoxicity. May prolong QT interval; use caution in patients with known QT prolongation, electrolyte abnormalities, or taking other QT-prolonging drugs. Use during pregnancy only if clearly needed. Excreted in human milk; caution when administering to nursing women. Superinfection with resistant organisms may occur. Not recommended for patients with pneumonia who are judged to be inappropriate for oral therapy.
Contraindications
Known hypersensitivity to azithromycin, erythromycin, or any other macrolide antibiotics. Contraindicated in patients with history of cholestatic jaundice/hepatic dysfunction associated with prior azithromycin use. Should not be used concomitantly with ergot derivatives or drugs that significantly prolong QT interval such as pimozide.
Possible side effects
Common adverse reactions (≥1%) include diarrhea/loose stools (4–5%), nausea (3%), abdominal pain (2–3%), and vomiting (1%). Less frequent side effects may include headache, dizziness, rash, and elevated liver enzymes. Serious but rare side effects include QT prolongation, hepatotoxicity, Clostridium difficile-associated diarrhea, and allergic reactions including anaphylaxis.
Drug interaction
Significant interactions with warfarin (monitor INR), digoxin (monitor levels), cyclosporine (monitor levels), and ergot derivatives (contraindicated). May increase concentrations of drugs metabolized by CYP3A4. Concomitant use with antacids containing aluminum or magnesium may reduce absorption. Caution with other QT-prolonging agents. May potentiate nephrotoxicity when used with other nephrotoxic drugs.
Missed dose
Take the missed dose as soon as remembered. If it is almost time for the next dose, skip the missed dose and continue with regular dosing schedule. Do not double the dose to make up for a missed dose. Maintain the prescribed interval between doses.
Overdose
Symptoms may include nausea, vomiting, diarrhea, and reversible hearing loss. Management is supportive with ECG monitoring for QT prolongation. Gastric lavage may be considered if presented soon after ingestion. Not removed by peritoneal dialysis or hemodialysis.
Storage
Store at 20–25°C (68–77°F). Excursions permitted to 15–30°C (59–86°F). Keep container tightly closed. Protect from moisture. Oral suspension: after reconstitution, store at 5–30°C (41–86°F) and use within 10 days. Keep out of reach of children.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment recommendations. Do not self-medicate or alter prescribed dosages without medical supervision. The prescribing physician should be aware of the patient’s complete medical history and concurrent medications.
Reviews
Clinical studies demonstrate azithromycin’s efficacy with cure rates of 85–95% for approved indications. Healthcare providers report high patient satisfaction due to convenient dosing schedule. Some reviews note gastrointestinal side effects as the most common reason for discontinuation. Overall considered a well-tolerated and effective antibiotic option when used appropriately for susceptible organisms.